...
首页> 外文期刊>CNS neuroscience & therapeutics. >A novel DNA repair‐related nomogram predicts survival in low‐grade gliomas
【24h】

A novel DNA repair‐related nomogram predicts survival in low‐grade gliomas

机译:一种新型DNA修复相关的ROM图预测低级GLIMAS的存活

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Aims We aimed to create a tumor recurrent‐based prediction model to predict recurrence and survival in patients with low‐grade glioma. Methods This study enrolled 291 patients (188 in the training group and 103 in the validation group) with clinicopathological information and transcriptome sequencing data. LASSO‐COX algorithm was applied to shrink predictive factor size and build a predictive recurrent signature. GO, KEGG, and GSVA analyses were performed for function annotations of the recurrent signature. The calibration curves and C‐Index were assessed to evaluate the nomogram's performance. Results This study found that DNA repair functions of tumor cells were significantly enriched in recurrent low‐grade gliomas. A predictive recurrent signature, built by the LASSO‐COX algorithm, was significantly associated with overall survival and progression‐free survival in low‐grade gliomas. Moreover, function annotations analysis of the predictive recurrent signature exhibited that the signature was associated with DNA repair functions. The nomogram, combining the predictive recurrent signature and clinical prognostic predictors, showed powerful prognostic ability in the training and validation groups. Conclusion An individualized prediction model was created to predict 1‐, 2‐, 3‐, 5‐, and 10‐year survival and recurrent rate of patients with low‐grade glioma, which may serve as a potential tool to guide postoperative individualized care.
机译:目的是我们旨在创造一种基于肿瘤经常性的预测模型,以预测低级胶质瘤患者的复发和生存。方法采用临床病理学信息和转录组测序数据注册了291名患者(188名培训组中的培训组和103例)。套索Cox算法应用于收缩预测因子尺寸并构建预测性复发性签名。 Go,Kegg和GSVA分析是针对经常性签名的函数注释进行的。评估校准曲线和C索引以评估墨顶图的性能。结果本研究发现,肿瘤细胞的DNA修复功能在复发性低级胶质瘤中显着富集。由洛索-COX算法构建的预测复发性签名与低级胶质瘤中的整体存活和无进展生存率显着相关。此外,函数注释对预测性复发特征的分析表明,签名与DNA修复功能有关。将预测性复发性签名和临床预测预测因子组合的载体图表在培训和验证组中表现出强大的预后能力。结论创建了个性化预测模型,以预测低级胶质瘤患者的1-,2-,3-,5-和10年存活率,可作为引导术后个性化护理的潜在工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号